Miloš Miljković

Miloš Miljković is the current Chief Medical Officer at Cartesian Therapeutics. Prior to their current position, Miloš Miljković served as an Assistant Research Physician at the National Cancer Institute from July 2017 to September 2021. Miloš also served as the Chief Fellow of Hematology/Oncology and as a Clinical Fellow of Hematology/Oncology at the National Cancer Institute from October 2016 to June 2017 and July 2014 to June 2017 respectively. In addition, Miloš Miljković was also a Chief Resident of Internal Medicine at LifeBridge Health from May 2013 to June 2014 and an Internal Medicine Resident at LifeBridge Health from June 2010 to June 2013. Furthermore, they served as a Teaching Assistant at Belgrade University School of Medicine’s Institute for Theirtology and Embryology from September 2009 to June 2010.

Miloš Miljković earned their MSc in Citology, Theirtochemistry, Electron Microscopy and Embryology from Belgrade University School of Medicine. Miloš then went on to earn their MD in Medicine from the University of Belgrade. Miloš has also earned certification from the American Board of Internal Medicine in Hematology, Medical Oncology, and Internal Medicine.

Their manager is Murat Kalayoglu, President & CEO. Some of their coworkers include Albina Benson - Senior Director, Manufacturing, Michael Singer - Chief Scientific Officer, and Metin Kurtoglu - COO. and Adam Chowdhury - Senior Director, Clinical Operations reports to Miloš Miljković.